Recovery of cardiac function mediated by MSC and interleukin-10 plasmid functionalised scaffold

Biomaterials

Volumn 33, Issue 5, 2012, Pages 1303-1314

  Holladay, Carolyn A ^a   Duffy, Aoife M ^a   Chen, Xizhe ^a   Sefton, Michael V ^b   O'Brien, Timothy D ^a   Pandit, Abhay S ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Anti inflammatory gene transfer; Cardiac tissue engineering; Interleukin 10; Mesenchymal stem cells; Scaffold

Indexed keywords

ANTI-INFLAMMATORIES; CARDIAC FUNCTIONS; CARDIAC TISSUE ENGINEERING; CELL DELIVERY SYSTEMS; CELL RETENTION; CLINICAL STUDY; COLLAGEN TYPE III; CYTOTOXIC; FUNCTIONAL RECOVERY; INFLAMMATORY RESPONSE; INTERLEUKIN-10; MESENCHYMAL STEM CELL; MYOCARDIAL INFARCTION; POSITIVE EFFECTS; STEM CELL TRANSPLANTATION; WALL THICKNESS;

CELL CULTURE; CELL DEATH; GENE TRANSFER; GENES; HEART; MOLECULAR BIOLOGY; RECOVERY; SCAFFOLDS; STEM CELLS; TISSUE;

SCAFFOLDS (BIOLOGY);

COLLAGEN TYPE 1; COLLAGEN TYPE 3; INTERLEUKIN 10; MOLECULAR SCAFFOLD;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; FEMALE; GENE TRANSFER; HEART FUNCTION; HEART INFARCTION; HEART INFARCTION SIZE; INFLAMMATION; MESENCHYMAL STEM CELL; NONHUMAN; PLASMID; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING;

ANIMALS; APOPTOSIS; EXTRACELLULAR MATRIX; FEMALE; HEART; INFLAMMATION; INTERLEUKIN-10; MACROPHAGES; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MYOCARDIAL INFARCTION; PHENOTYPE; PLASMIDS; RATS; RATS, INBRED LEW; RECOVERY OF FUNCTION; TISSUE SCAFFOLDS;

EID: 83355173918     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.10.019     Document Type: Article

References (43)

1. Kim S.W., Han H., Chae G.T., Lee S.H., Bo S., Yoon J.H., et al. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model. Stem Cells 2006, 24(6):1620-1626.
2. Lindvall O., Kokaia Z. Stem cells in human neurodegenerative disorders - time for clinical translation?. J Clin Invest 2010, 120(1):29-40.
3. Orlic D., Kajstura J., Chimenti S., Jakoniuk I., Anderson S.M., Li B.S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410(6829):701-705.
4. Delcarpio J.B., Claycomb W.C. Cardiomyocyte transfer into the mammalian heart - cell-to-cell interactions in-vivo and in-vitro. Cardiac growth and regeneration 1995, 267-285. New York Acad Sciences, New York. W.C. Claycomb, P. DiNardo (Eds.).
5. Li R.K., Mickle D.A.G., Weisel R.D., Zhang J., Mohabeer M.K. In vivo survival and function of transplanted rat cardiomyocytes. Circ Res 1996, 78(2):283-288.
6. Nyolczas N., Gyöngyösi M., Beran G., Dettke M., Graf S., Sochor H., et al. Design and rationale for the myocardial stem cell administration after acute myocardial infarction (MYSTAR) study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction. Am Heart J 2007, 153(2):212.e1-212.e7.
7. Beitnes J.O., Hopp E., Lunde K., Solheim S., Arnesen H., Brinchmann J.E., et al. Long-term results after intracoronary injection of autologous mononuclear bone marrow cells in acute myocardial infarction: the ASTAMI randomised, controlled study. Heart 2009, 95(24):1983-1989.
8. Schachinger V., Erbs S., Elsasser A., Haberbosch W., Hambrecht R., Holschermann H., et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006, 355(12):1210-1221.
9. Ripa R.S., Kastrup J. REGENT trial-the end of cell therapy for MI?. Nat Rev Cardio 2009, 6(9):567-568.
10. Meyer G.P., Wollert K.C., Lotz J., Pirr J., Rager U., Lippolt P., et al. Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. Eur Heart J 2009, 30(24):2978-2984.
11. Pons J., Huang Y., Takagawa J., Arakawa-Hoyt J., Ye J., Grossman W., et al. Combining angiogenic gene and stem cell therapies for myocardial infarction. J Gene Med 2009, 11(9):743-753.
12. Egdell R.M., Siminiak T., Sheridan D.J. Modulation of neutrophil activity by nitric-oxide during acute myocardial ischemia and reperfusion. Basic Res Cardiol 1994, 89(6):499-509.
13. Yang Z., Zingarelli B., Szabo C. Crucial role of endogenous interleukin-10 production in myocardial ischemia/reperfusion injury. Circulation 2000, 101(9):1019-1026.
14. Chen H., Mohuczy D., Li D., Kimura B., Phillips M.I., Mehta P., et al. Protection against ischemia/reperfusion injury and myocardial dysfunction by antisense-oligodeoxynucleotide directed at angiotensin-converting enzyme mRNA. Gene Ther 2001, 8(10):804-810.
15. Suzuki K., Murtuza B., Smolenski R.T., Sammut I.A., Suzuki N., Kaneda Y., et al. Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemia-reperfusion injury associated with reduction in apoptosis. Circulation 2001, 104(12):I308-I313.
16. Holladay C., Power K., Sefton M., O'Brien T., Gallagher W.M., Pandit A. Functionalized scaffold-mediated interleukin 10 gene delivery significantly improves survival rates of stem cells in vivo. Mol Ther 2011, 19(5):969-978.
17. Hong Y.S., Laks H., Cui G., Chong T., Sen L. Localized immunosuppression in the cardiac allograft induced by a new liposome-mediated IL-10 gene therapy. J Heart Lung Transplant 2002, 21(11):1188-1200.
18. Dudler J., Li J.P., Pagnotta M., Pascual M., von Segesser L.K., Vassalli G. Gene transfer of programmed death ligand-1.Ig prolongs cardiac allograft survival. Transplantation 2006, 82(12):1733-1737.
19. Manning E., Pham S., Li S., Vazquez-Padron R.I., Mathew J., Ruiz P., et al. Interleukin-10 delivery via mesenchymal stem cells: a novel gene therapy approach to prevent lung ischemia-reperfusion injury. Hum Gene Ther 2010, 21(6):713-727.
20. van Putten S.M., Wubben M., Hennink W.E., van Luyna M.J.A., Harmsen M.C. The downmodulation of the foreign body reaction by cytomegalovirus encoded interleukin-10. Biomaterials 2009, 30(5):730-735.
21. Stumpf C., Seybold K., Petzi S., Wasmeier G., Raaz D., Yilmaz A., et al. Interleukin-10 improves left ventricular function in rats with heart failure subsequent to myocardial infarction. Eur J Heart Fail 2008, 10(8):733-739.
22. Bhavsar M.D., Amiji M.M. Oral IL-10 gene delivery in a microsphere-based formulation for local transfection and therapeutic efficacy in inflammatory bowel disease. Gene Ther 2008, 15(17):1200-1209.
23. Hoare M., Greiser U., Schu S., Mashayekhi K., Aydogan E., Murphy M., et al. Enhanced lipoplex-mediated gene expression in mesenchymal stem cells using reiterated nuclear localization sequence peptides. J Gene Med 2010, 12(2):207-218.
24. Holladay C., Keeney M., Greiser U., Murphy M., O'Brien T., Pandit A. A matrix reservoir for improved control of non-viral gene delivery. J Control Release 2009, 136(3):220-225.
25. Badylak S.F., Valentin J.E., Ravindra A.K., McCabe G.P., Stewart-Akers A.M. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng A 2008, 14(11):1835-1842.
26. Brown B.N., Valentin J.E., Stewart-Akers A.M., McCabe G.P., Badylak S.F. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 2009, 30(8):1482-1491.
27. Takagawa J., Zhang Y., Wong M.L., Sievers R.E., Kapasi N.K., Wang Y., et al. Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J Appl Physiol 2007, 102(6):2104-2111.
28. ter Horst K.W. Stem cell therapy for myocardial infarction: are we missing time?. Cardiology 2010, 117(1):1-10.
29. Zhang G., Hu Q., Braunlin E.A., Suggs L.J., Zhang J. Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix. Tissue Eng A 2008, 14(6):1025.
30. Dubois G., Segers V.F.M., Bellamy V., Sabbah L., Peyrard S., Bruneval P., et al. Self-assembling peptide nanofibers and skeletal myoblast transplantation in infarcted myocardium. J Biomed Mater Res Part B 2008, 87B(1):222-228.
31. Matsumoto R., Omura T., Yoshiyama M., Hayashi T., Inamoto S., Koh K.-R., et al. Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler Thromb Vasc Biol 2005, 25(6):1168-1173.
32. Mizuno T., Yau T.M., Weisel R.D., Kiani C.G., Li R.K. Elastin stabilizes an infarct and preserves ventricular function. Circulation 2005, 112(9):I81-I88.
33. Dai W.D., Hale S.L., Kay G.L., Jyrala A.J., Kloner R.A. Delivering stem cells to the heart in a collagen matrix reduces relocation of cells to other organs as assessed by nanoparticle technology. Regen Med 2009, 4(3):387-395.
34. Derval N., Barandon L., Dufourcq P., Leroux L., Lamaziere J.M.D., Daret D., et al. Epicardial deposition of endothelial progenitor and mesenchymal stem cells in a coated muscle patch after myocardial infarction in a murine model. Eur J Cardiothorac Surg 2008, 34(2):248-254.
35. Giraud M.-N., Ayuni E., Cook S., Siepe M., Carrel T.P., Tevaearai H.T. Hydrogel-based engineered skeletal muscle grafts normalize heart function early after myocardial infarction. Artif Organs 2008, 32:692-700.
36. van den Bos E.J., Mees B.M.E., de Waard M.C., de Crom R., Duncker D.J. A novel model of cryoinjury-induced myocardial infarction in the mouse: a comparison with coronary artery ligation. Am J Physiol Heart Circ Physiol 2005, 289(3):H1291-H1300.
37. Chen Q.-Z., Harding S.E., Ali N.N., Lyon A.R., Boccaccini A.R. Biomaterials in cardiac tissue engineering: ten years of research survey. Mater Sci Eng R: Rep 2008, 59(1-6):1-37.
38. Kakkar R., Lee R.T. Intramyocardial fibroblast myocyte communication. Circ Res 2010, 106(1):47-57.
39. Marijianowski M.M.H., Teeling P., Mann J., Becker A.E. Dilated cardiomyopathy is associated with an increase in the type-I/type-III collagen ratio - a quantitative assessment. J Am Coll Cardiol 1995, 25(6):1263-1272.
40. Łukasz Karpiński R.P., Kosmala Wojciech, Witkowska Maria Serum levels of interleukin-6, interleukin-10 and C-reactive protein in relation to left ventricular function in patients with myocardial infarction treated with primary angioplasty. Kardiol Pol 2008, 66:1279-1285.
41. Jaremo P., Nilsson O. Interleukin-6 and neutrophils are associated with long-term survival after acute myocardial infarction. Eur J Intern Med 2008, 19(5):330-333.
42. Valentin J.E., Stewart-Akers A.M., Gilbert T.W., Badylak S.F. Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds. Tissue Eng A 2009, 15(7):1687-1694.
43. Mosser D.M. The many faces of macrophage activation. J Leukoc Biol 2003, 73(2):209-212.